Nifty
Sensex
:
:
12968.95
44149.72
-18.05 (-0.14%)
-110.02 (-0.25%)

Pharmaceuticals & Drugs - API

Rating :
38/99  (View)

BSE: 530239 | NSE: SUVEN

46.45
-0.50 (-1.06%)
27-Nov-2020 | 3:59PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  47.05
  •  47.95
  •  46.25
  •  46.95
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  515596
  •  239.49
  •  322.00
  •  15.20

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 591.86
  • N/A
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 578.80
  • N/A
  • 5.05

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 60.00%
  • 1.20%
  • 32.53%
  • FII
  • DII
  • Others
  • 1.02%
  • 0.25%
  • 5.00%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -20.91
  • -50.79
  • -71.54

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 33.30
  • 27.80
  • 25.91

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 5.31
  • 3.77
  • 3.55

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 32.85
  • 13.95
  • 11.41

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Net Sales
9
1
546%
1
2
-11%
9
2
264%
3
2
31%
Expenses
27
22
18%
16
43
-64%
34
51
-33%
30
22
39%
EBITDA
-18
-21
-
-14
-42
-
-25
-48
-
-28
-20
-
EBIDTM
-196%
-1,520%
-993%
-2,627%
14%
-2,025%
-998%
-939%
Other Income
2
2
-4%
3
3
-10%
3
6
-48%
6
7
-13%
Interest
0
0
136%
0
0
100%
0
0
-21%
0
0
0
Depreciation
1
1
-25%
1
1
25%
1
1
31%
1
1
-13%
PBT
-17
-20
-
-13
-40
-
-23
-44
-
-23
-14
-
Tax
-1
0
-
-2
-14
-
2
-4
-
0
0
-90%
PAT
-16
-20
-
-10
-26
-
-26
-39
-
-23
-14
-
PATM
-174%
-1,429%
-734%
-1,632%
7%
-1,657%
-823%
-684%
EPS
-1.23
-1.56
-
-0.82
-2.04
-
-2.01
-3.10
-
-1.79
-1.13
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 08
Mar 07
Mar 06
Mar 05
Net Sales
22
14
286
625
544
500
521
117
112
88
64
Net Sales Growth
192%
-95%
-54%
15%
9%
-4%
344%
5%
27%
38%
 
Cost Of Goods Sold
4,644
0
69
152
147
163
178
44
42
31
20
Gross Profit
-4,622
14
217
473
396
337
343
73
70
57
44
GP Margin
-21,164%
100%
76%
76%
73%
67%
66%
62%
62%
65%
69%
Total Expenditure
106
130
297
424
414
398
361
105
96
77
55
Power & Fuel Cost
-
2
19
34
32
29
28
8
6
6
5
% Of Sales
-
11%
7%
5%
6%
6%
5%
7%
6%
7%
8%
Employee Cost
-
17
36
61
52
36
32
12
10
7
6
% Of Sales
-
121%
13%
10%
10%
7%
6%
10%
9%
8%
10%
Manufacturing Exp.
-
103
147
144
154
139
96
30
28
25
16
% Of Sales
-
717%
51%
23%
28%
28%
18%
25%
25%
29%
26%
General & Admin Exp.
-
5
13
21
19
22
20
8
8
6
5
% Of Sales
-
34%
5%
3%
4%
4%
4%
7%
7%
7%
8%
Selling & Distn. Exp.
-
0
5
9
7
7
5
2
2
2
2
% Of Sales
-
0%
2%
1%
1%
1%
1%
2%
2%
2%
3%
Miscellaneous Exp.
-
3
7
3
3
2
3
0
0
1
2
% Of Sales
-
20%
2%
1%
1%
0%
1%
0%
0%
1%
0%
EBITDA
-85
-116
-11
202
129
101
159
13
16
11
9
EBITDA Margin
-387%
-803%
-4%
32%
24%
20%
31%
11%
15%
12%
13%
Other Income
14
14
27
23
21
20
9
3
1
1
2
Interest
1
1
2
5
6
6
5
5
3
2
1
Depreciation
4
4
14
25
21
18
12
4
4
3
3
PBT
-76
-106
0
196
123
98
152
6
11
6
6
Tax
-1
-12
24
72
36
26
43
-2
-1
0
4
Tax Rate
2%
11%
15,038%
37%
29%
26%
28%
-31%
-5%
2%
60%
PAT
-75
-94
-24
124
87
72
109
8
11
6
2
PAT before Minority Interest
-75
-94
-24
124
87
72
109
8
11
6
2
Minority Interest
0
0
0
0
0
0
0
0
0
0
0
PAT Margin
-341%
-654%
-8%
20%
16%
14%
21%
7%
10%
7%
4%
PAT Growth
0%
-294%
-119%
42%
21%
-34%
1,202%
-26%
76%
165%
 
EPS
-5.85
-7.40
-1.88
9.72
6.85
5.64
8.54
0.66
0.88
0.50
0.19

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 08
Mar 07
Mar 06
Mar 05
Shareholder's Funds
143
239
767
667
595
559
106
102
90
81
Share Capital
13
13
13
13
13
13
12
6
5
5
Total Reserves
131
226
755
654
583
547
95
96
85
76
Non-Current Liabilities
12
25
30
28
41
86
57
47
31
33
Secured Loans
0
0
0
23
37
55
55
41
24
20
Unsecured Loans
1
2
2
3
5
6
0
0
0
0
Long Term Provisions
2
1
4
3
2
2
0
0
0
0
Current Liabilities
120
157
226
208
211
127
35
25
22
22
Trade Payables
6
7
57
38
36
44
20
12
12
12
Other Current Liabilities
20
32
29
46
48
42
1
1
0
0
Short Term Borrowings
0
0
31
30
24
28
0
0
0
0
Short Term Provisions
94
118
109
93
103
13
14
12
10
9
Total Liabilities
275
421
1,023
903
846
773
199
173
143
136
Net Block
25
22
308
306
305
172
110
96
83
74
Gross Block
44
39
376
349
325
291
141
120
102
89
Accumulated Depreciation
19
17
68
43
20
119
31
25
19
14
Non Current Assets
116
22
350
322
319
291
116
106
90
85
Capital Work in Progress
0
0
25
10
7
107
4
5
3
3
Non Current Investment
0
0
0
0
0
0
2
5
4
7
Long Term Loans & Adv.
91
0
17
6
6
11
0
0
0
0
Other Non Current Assets
0
0
0
0
0
1
0
0
0
0
Current Assets
160
398
674
581
528
477
83
68
53
51
Current Investments
0
223
279
301
0
0
0
0
0
0
Inventories
0
0
139
93
83
82
24
23
23
19
Sundry Debtors
2
3
62
46
54
40
36
16
15
19
Cash & Bank
15
1
28
9
241
280
3
10
1
3
Other Current Assets
142
3
50
33
149
75
20
19
14
11
Short Term Loans & Adv.
141
169
116
100
109
34
15
14
10
9
Net Current Assets
39
241
448
373
317
350
48
43
31
30
Total Assets
275
421
1,023
903
846
773
199
173
143
136

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 08
Mar 07
Mar 06
Mar 05
Cash From Operating Activity
-194
-53
70
109
68
4
16
6
2
PBT
-106
0
196
123
98
6
11
6
6
Adjustment
18
-5
10
13
11
11
7
7
4
Changes in Working Capital
-103
-33
-92
8
-14
-13
0
-7
-7
Cash after chg. in Working capital
-191
-38
113
144
94
5
18
7
3
Interest Paid
0
0
0
0
0
0
0
0
0
Tax Paid
-3
-15
-44
-35
-27
-1
-2
-1
-1
Other Direct Exp. Paid
0
0
0
0
0
0
0
0
0
Extra & Other Items
0
0
0
0
0
0
0
0
0
Cash From Investing Activity
206
37
-1
-311
-39
-16
-20
-9
-4
Net Fixed Assets
-4
361
-42
-26
-187
-19
-21
-14
Net Investments
117
22
-15
-343
-15
3
-1
4
Others
92
-346
56
59
164
0
2
0
Cash from Financing Activity
3
5
-52
-30
-68
6
13
3
-8
Net Cash Inflow / Outflow
14
-11
17
-232
-39
-7
8
-1
-10
Opening Cash & Equivalents
0
18
9
241
280
10
1
3
12
Closing Cash & Equivalent
15
0
26
9
241
3
10
1
3

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 08
Mar 07
Mar 06
Mar 05
Book Value (Rs.)
11
19
60
52
47
44
9
35
9
8
ROA
-27%
-3%
13%
10%
9%
22%
4%
7%
5%
2%
ROE
-49%
-5%
17%
14%
12%
33%
8%
12%
7%
3%
ROCE
-55%
0%
26%
18%
15%
38%
8%
11%
8%
7%
Fixed Asset Turnover
0.35
1.38
1.73
1.62
1.63
2.42
0.92
1.02
0.95
0.80
Receivable days
62
41
31
33
34
27
79
50
68
82
Inventory Days
0
0
68
59
60
37
72
74
85
87
Payable days
19
39
39
33
36
33
57
46
53
66
Cash Conversion Cycle
44
2
60
59
59
31
93
78
100
103
Total Debt/Equity
0.01
0.01
0.04
0.11
0.14
0.20
0.51
0.41
0.26
0.24
Interest Cover
-192
1
43
23
18
33
2
5
5
8

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.